NDC 51662-1410

PYRIDOXINE HCI

Pyridoxine Hci

PYRIDOXINE HCI is a Intramuscular; Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Pyridoxine Hydrochloride.

Product ID51662-1410_946c8e50-08d1-755d-e053-2a95a90a84de
NDC51662-1410
Product TypeHuman Prescription Drug
Proprietary NamePYRIDOXINE HCI
Generic NamePyridoxine Hci
Dosage FormInjection, Solution
Route of AdministrationINTRAMUSCULAR; INTRAVENOUS
Marketing Start Date2019-10-08
Marketing CategoryANDA / ANDA
Application NumberANDA080618
Labeler NameHF Acquisition Co LLC, DBA HealthFirst
Substance NamePYRIDOXINE HYDROCHLORIDE
Active Ingredient Strength100 mg/mL
Pharm ClassesVitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 51662-1410-1

1 mL in 1 VIAL (51662-1410-1)
Marketing Start Date2019-10-08
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51662-1410-1 [51662141001]

PYRIDOXINE HCI INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA080618
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-10-08

Drug Details

Active Ingredients

IngredientStrength
PYRIDOXINE HYDROCHLORIDE100 mg/mL

OpenFDA Data

SPL SET ID:946c8e50-08d0-755d-e053-2a95a90a84de
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 312736
  • UPC Code
  • 0363323180010
  • Pharmacological Class

    • Vitamin B6 Analog [EPC]
    • Vitamin B 6 [Chemical/Ingredient]
    • Analogs/Derivatives [Chemical/Ingredient]

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.